ActivityPub Viewer

A small tool to view real-world ActivityPub objects as JSON! Enter a URL or username from Mastodon or a similar service below, and we'll send a request with the right Accept header to the server to view the underlying object.

Open in browser →
{ "@context": [ "https://www.w3.org/ns/activitystreams", { "ostatus": "http://ostatus.org#", "atomUri": "ostatus:atomUri", "inReplyToAtomUri": "ostatus:inReplyToAtomUri", "conversation": "ostatus:conversation", "sensitive": "as:sensitive", "toot": "http://joinmastodon.org/ns#", "votersCount": "toot:votersCount", "blurhash": "toot:blurhash", "focalPoint": { "@container": "@list", "@id": "toot:focalPoint" }, "Hashtag": "as:Hashtag" } ], "id": "https://respublicae.eu/users/mgracacarvalho/statuses/109880052880831049", "type": "Note", "summary": null, "inReplyTo": null, "published": "2023-02-17T12:22:29Z", "url": "https://respublicae.eu/@mgracacarvalho/109880052880831049", "attributedTo": "https://respublicae.eu/users/mgracacarvalho", "to": [ "https://www.w3.org/ns/activitystreams#Public" ], "cc": [ "https://respublicae.eu/users/mgracacarvalho/followers", "https://respublicae.eu/users/EMA_News" ], "sensitive": false, "atomUri": "https://respublicae.eu/users/mgracacarvalho/statuses/109880052880831049", "inReplyToAtomUri": null, "conversation": "tag:respublicae.eu,2023-02-17:objectId=2176694:objectType=Conversation", "content": "<p>RT @ESCAdvocacy: A major setback for cardiovascular care with no new medicines approved in 2022, according to <span class=\"h-card\"><a href=\"https://respublicae.eu/@EMA_News\" class=\"u-url mention\">@<span>EMA_News</span></a></span>. @escardio calls on policymakers to prioritize <a href=\"https://respublicae.eu/tags/CardiovascularHealth\" class=\"mention hashtag\" rel=\"tag\">#<span>CardiovascularHealth</span></a> and support the development of new <a href=\"https://respublicae.eu/tags/therapies\" class=\"mention hashtag\" rel=\"tag\">#<span>therapies</span></a> that make a difference for <a href=\"https://respublicae.eu/tags/patients\" class=\"mention hashtag\" rel=\"tag\">#<span>patients</span></a>. <a href=\"https://www.ema.europa.eu/en/documents/report/human-medicines-highlights-2022_en.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">ema.europa.eu/en/documents/rep</span><span class=\"invisible\">ort/human-medicines-highlights-2022_en.pdf</span></a> </p><p> 🐦🔗: <a href=\"https://n.respublicae.eu/mgracacarvalho/status/1626545206962139137\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">n.respublicae.eu/mgracacarvalh</span><span class=\"invisible\">o/status/1626545206962139137</span></a></p>", "contentMap": { "pt": "<p>RT @ESCAdvocacy: A major setback for cardiovascular care with no new medicines approved in 2022, according to <span class=\"h-card\"><a href=\"https://respublicae.eu/@EMA_News\" class=\"u-url mention\">@<span>EMA_News</span></a></span>. @escardio calls on policymakers to prioritize <a href=\"https://respublicae.eu/tags/CardiovascularHealth\" class=\"mention hashtag\" rel=\"tag\">#<span>CardiovascularHealth</span></a> and support the development of new <a href=\"https://respublicae.eu/tags/therapies\" class=\"mention hashtag\" rel=\"tag\">#<span>therapies</span></a> that make a difference for <a href=\"https://respublicae.eu/tags/patients\" class=\"mention hashtag\" rel=\"tag\">#<span>patients</span></a>. <a href=\"https://www.ema.europa.eu/en/documents/report/human-medicines-highlights-2022_en.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://www.</span><span class=\"ellipsis\">ema.europa.eu/en/documents/rep</span><span class=\"invisible\">ort/human-medicines-highlights-2022_en.pdf</span></a> </p><p> 🐦🔗: <a href=\"https://n.respublicae.eu/mgracacarvalho/status/1626545206962139137\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">n.respublicae.eu/mgracacarvalh</span><span class=\"invisible\">o/status/1626545206962139137</span></a></p>" }, "attachment": [ { "type": "Document", "mediaType": "image/jpeg", "url": "https://files.respublicae.eu/media_attachments/files/109/880/052/832/545/749/original/697aea8c79b000de.jpg", "name": null, "blurhash": "UBR{#?IoD%%Lj[ayj[WB00t6ofRkxuRjayt7", "width": 1200, "height": 675 } ], "tag": [ { "type": "Mention", "href": "https://respublicae.eu/users/EMA_News", "name": "@EMA_News" }, { "type": "Hashtag", "href": "https://respublicae.eu/tags/cardiovascularhealth", "name": "#cardiovascularhealth" }, { "type": "Hashtag", "href": "https://respublicae.eu/tags/therapies", "name": "#therapies" }, { "type": "Hashtag", "href": "https://respublicae.eu/tags/patients", "name": "#patients" } ], "replies": { "id": "https://respublicae.eu/users/mgracacarvalho/statuses/109880052880831049/replies", "type": "Collection", "first": { "type": "CollectionPage", "next": "https://respublicae.eu/users/mgracacarvalho/statuses/109880052880831049/replies?only_other_accounts=true&page=true", "partOf": "https://respublicae.eu/users/mgracacarvalho/statuses/109880052880831049/replies", "items": [] } } }